Skip to main content

International Thoracic Surgical Oncology Summit

A Virtual Learning Experience
October 16-17, 2020



Program

FRIDAY, OCTOBER 16, 2020

The Virtual Poster Hall highlights accepted abstracts, and will be available to view for the duration of the program.

 

8:30AM-10:30AM PLENARY SESSION I: LUNG CANCER ADVANCES: TUMOR BIOLOGY, IMMUNOTHERAPY, AND ctDNA
Moderators:
David R. Jones, Memorial Sloan Kettering Cancer Center
G. Alexander Patterson, Washington University School of Medicine
  Welcoming Remarks
David R. Jones, Memorial Sloan Kettering Cancer Center
  David J. Sugarbaker Memorial Lecture: The Evolution of Surgery for Stage III NSCLC
Walter Weder, Thoraxchirurgie Bethanien
  Spread Through Air Spaces (STAS) in Non-Small Cell Lung Cancer: Evidence Supportive of an In Vivo Biologic Process
Daniel Gross, Memorial Sloan Kettering Cancer Center
  Optimal Lymphadenectomy in Wedge Resection for Early Non-Small Cell Lung Cancer
 
A. Justin Rucker, Duke University Medical Center
  Understanding the Biology of Lung Adenocarcinoma Histologic Subtypes through Tumor Genomics
David R. Jones, Memorial Sloan Kettering Cancer Center

Believe it or Not: STAS is a Pathologic Driver of Recurrence and Poor Prognosis
Prasad S. Adusumilli, Memorial Sloan Kettering Cancer Center

Update on Immune Checkpoint Inhibitors in Operable NSCLC
Thomas E. Stinchcombe, Duke University Medical Center

The Emerging Role of ctDNA as a Biomarker for MRD and Treatment Decision-Making in NSCLC
Maximilian Diehn, Stanford University Medical Center
  Live Panel Discussion
   
10:30AM-12:00PM
CONCURRENT SESSION A: MULTIDISCIPLINARY INDUCTION STRATEGIES IN THE TREATMENT OF OPERABLE ESOPHAGEAL CANCER
Moderators:
James D. Luketich, University of Pittsburgh Medical Center
Daniela Molena, Memorial Sloan Kettering Cancer Center
  The Prognostic Value of the Radial Margin of Resection in Patients Undergoing Esophagectomy
Rebecca Carr, Memorial Sloan Kettering Cancer Center

Neoadjuvant Therapy Combined with Surgery is Superior to Chemoradiotherapy in Esophageal Squamous Cell Cancer Patients with Resectable Supraclavicular Lymph Node Metastasis: A Propensity Score-Matced Analysis
Yongkui Yu, Chinese Academy of Medical Sciences and Peking Union Medical College
  Moving Beyond CROSS: Emerging Induction Strategies for Esophageal Cancer
Yelena Y. Janjigian, Memorial Sloan Kettering Cancer Center

Should Radiation Be a Component of Induction Regimens for Esophageal Adenocarcinoma?
James D. Luketich, University of Pittsburgh Medical Center

Management of Locoregional Recurrence S/P Trimodality Therapy
Daniela Molena, Memorial Sloan Kettering Cancer Center

Live Panel Discussion
   
10:30AM-12:00PM CONCURRENT SESSION B:  HOW I DO IT: MINIMALLY-INVASIVE PULMONARY RESECTIONS
Moderators:
Haiquan Chen, Fudan University Shanghai Cancer Center
Scott J. Swanson, Brigham and Women's Hospital
  Invited Master Surgeon Lecture: Morihoto Okada, Hiroshima University
Technical Caveats for Thoracoscopic Segmentectomy
  Robotic Segmentectomy s/p Induction Chemotherapy
Benny Weksler, Allegheny General Hospital
  Uniportal VATS Sleeve Resection
Diego Gonzalez-Rivas, Coruna University Hospital
  Thoracoscopic Lobectomy Following Induction Immunotherapy
Thomas A. D'Amico, Duke University Medical Center
  Thoracoscopic Lobectomy s/p Osimertinib Induction Therapy
David R. Jones, Memorial Sloan Kettering Cancer Center
  Live Panel Discussion
   
12:00PM-1:00PM INDUSTRY SPONSORED LUNCH SYMPOSIA
   
1:00PM-2:25PM CONCURRENT SESSION C: PULMONARY METASTASECTOMY
Moderators:
Gaetano Rocco, Memorial Sloan Kettering Cancer Center
Harvey I. Pass, New York University School of Medicine
  Major Tumor Resection Versus Pleural Biopsy in EGFR-Mutant Patients with Pleural Metastases: Results of Chinese Multicenter Study
Ke-Neng Chen, Peking University Cancer Hospital and Institute
  Tumor Histology and Biology: Implications for Pulmonary Metastasectomy
Bryan M. Burt, Baylor College of Medicine
  What's Wrong with Selection Bias for Pulmonary Metastasectomy?
Garrett L. Walsh, MD Anderson Cancer Center
  Hybrid Approaches to Managing Pulmonary Metastases
Michael Lanuti, Massachusetts General Hospital
  Who Is Not a Candidate for Pulmonary Metastasectomy?
Gaetano Rocco, Memorial Sloan Kettering Cancer Center
  Live Panel Discussion
   
1:00PM-2:25PM CONCURRENT SESSION D: EVOLVING THERAPIES IN THE SURGICAL MANAGEMENT OF LUNG CANCER
Moderators:
Shaf Keshavjee, Toronto General Hospital 
Chadrick E. Denlinger, Indiana University 
  Estimating the Impact of Extended Delay Surgery for Stage I Non-Small Cell Lung Cancer on Survival During the COVID-19 Pandemic
Nicholas Mayne, Duke University Medical Center
  Salvage Pulmonary Resections: Indications and Results
Hiroshi Date, Kyoto University
  Targeting KRAS G12C: Implications for Thoracic Surgeons
Bob T. Li, Memorial Sloan Kettering Cancer Center
  Lung Cancer Surgery in the COVID Era: Patient Prioritization, Results and Recommendations
Scott J. Swanson, Brigham & Women's Hospital
  Surgical Strategies 3.0 for Preinvasive Lung Adenocarcinoma
Haiquan Chen, Fudan University Shanghai Cancer Center

Live Panel Discussion
   
2:30PM-4:30PM PLENARY SESSION 2: LIVE SURGERY WITH ROBERT J. CERFOLIO
Moderators:
Bernard J. Park, Memorial Sloan Kettering Cancer Center
Mark Onaitis, University of California San Diego
Surgeon: Robert J. Cerfolio, New York University School of Medicine
   
  DAY 1 ADJOURNS
   
SATURDAY, OCTOBER 17, 2020

 

 7:00AM-8:00AM  BREAKFAST SESSION - UPDATE ON CLINICAL TRIALS IN THORACIC ONCOLOGIC SURGERY
Moderators:
James Huang, Memorial Sloan Kettering Cancer Center
Christopher W. Seder, Rush University Medical Center
   Canakinumab (CAN) or Pembrolizumab (PEM) in Patients with Surgically Resected Non-Small Cell Lung Cancer (NSCLC) as Monotherapy or in Combination as Neoadjuvant Therapy: CANOPY-N Trial
Jay M. Lee, University of California Los Angeles
   Image-Guided Combined Ablation and Resection in Thoracic Surgery (iCART) with Siemens ARTIS Pheno Intra-Operative Cone Beam CT
Oliver J. Harrison, University Hospital Southampton, UK
   Phase II Evaluation of a Cancer Cell Lysate Vaccine in Patients with Thoracic Malignancies
David S. Schrump, National Cancer Institute
   Preoperative Pembrolizumab Combined with Chemoradiotherapy for Oesphageal Squamos Cell Carcinoma (PALACE-1)
Hecheng Li, Rujin Hospital
   
8:00AM-10:00AM PLENARY SESSION 3: LUNG CANCER ADVANCES: ADJUVANT THERAPY, STAGING, AND TEACHING
Moderators:
Thomas A. D'Amico, Duke University Medical Center
Jessica S. Donington, The University of Chicago Medical Center
  Analysis of Preoperative Clinical and Tumor Genomic Features Associated with Pathologic Lymph Node Metastasis in Clinical Stage I and II Lung Adenocarcinoma
David R. Jones, Memorial Sloan Kettering Cancer Center
  Visceral Obesity Promotes Lung Cancer Progression
Sai Yendamuri, Rosewell Park Cancer Center
  Osimerinib as Adjuvant Therapy in Patients with Stage IB-IIIA EGFR Mutation Positive NSCLC After Complete Tumor Resection: ADAURA
Roy Herbst, Yale Comprehensive Cancer Center
  Re-Categorization of the Residual Tumor (R) Classification: Is There Added Value?
Thomas A. D'Amico, Duke University Medical Center
  Teaching Lung Cancer Surgery Virtually in the COVID Pandemic
Laura Donahoe, Toronto General Hospital
  Live Panel Discussion
   
10:00AM-11:55AM CONCURRENT SESSION E: ADVANCES IN ESOPHAGEAL CANCER SURGERY: DETECTION, ENDOSCOPIC MANAGEMENT AND COMPLICATIONS
Moderators:
Nassar Altorki, New York Hospital Cornell Medical Center
M. Blair Marshall, Brigham and Women's Hospital
  Fewer Complication Rates Among High-Volume Versus Low-Volume Esophagectomy Surgeons at a High-Volume Center
Daniel Dolan, Brigham and Women's Hospital
   Venous Thrombeombolism in Surgically Treated Esophageal Cancer Patients: A Provincial Population-Based Study
Gileh-Gol Aktar-Danesh, McMaster University
  Update on the Management of Barrett's Esophagus
Giovanni Zaninotto, Imperial College
  Esophageal Anastomotic Leaks: Stents and Other Options
Wayne L. Hofstetter, MD Anderson Cancer Center
  Skill Sets for the Contemporary Esophageal Surgeon: EUS, EMR, RFA, and ESD
Daniela Molena, Memorial Sloan Kettering Cancer Center
  Navigating Challenging Dissections with MIE
Scott J. Swanson, Brigham and Women's Hospital
  Para-Conduit Hernias s/p MIE
Jon O. Wee, Brigham and Women's Hospital
  Live Panel Discussion
   
10:00AM-11:55AM


CONCURRENT SESSION F: DISPARITIES IN CARE OF THE THORACIC ONCOLOGIC PATIENT
Moderators:
Alessandro Brunelli, St. James Hospital
Yolonda L. Colson, Massachusetts General Hospital
  Treatment Delays Contribute to Health Care Disparities and Affect Survival Outcomes in Non-Small Cell Lung Cancer
Zaid Muslim, Nuvance Health
  Invited Lecture: The Evolving Definition of Disparity in Cancer Care
Francesca M. Gany, Memorial Sloan Kettering Cancer Center
  Variations in Receipt of Curative-Intent Surgery for Early-Stage NSCLC
Raymond Osarogiagbon, BMG- Baptist Cancer Center Memphis
  Disparities in Guideline-Concordant Treatment for Node-Positive NSCLC Following Surgery
Betty C. Tong, Duke University Medical Center
  Lung Cancer Disparities in Latin Americans and Hispanics
Paula A. Ugalde, Institut Universitaire de Cardiologie
  Disparities in Esophageal Cancer Surgical Care
Nathaniel Evans, Thomas Jefferson University
  Mind the Gap: Precision Oncology and Its Potential to Widen Disparities
Ryan W. Huey, MD Anderson Cancer Center

Live Panel Discussion
   
11:55AM-12:55PM Industry Sponsored Lunch Symposia
   
  DAY 2 ADJOURNS
   
   
 
 
   
Times listed are Eastern Standard Time. Program subject to change.

The AATS International Thoracic Surgical Oncology Summit has been rated compliant with the MedTech Europe Code of Ethical Business Practice